Today: 20 May 2026
Experian PLC stock: EXPN slips into London open as Jan 21 trading update nears
13 January 2026
1 min read

Experian PLC stock: EXPN slips into London open as Jan 21 trading update nears

London, Jan 13, 2026, 07:57 GMT — Premarket

  • Shares tumbled 2.3% on Monday, lagging behind the FTSE 100
  • Experian’s third-quarter trading update on January 21 will be the next major catalyst
  • Analysts covering the company project FY26 revenue near $8.43 billion

Experian (EXPN.L) slipped 2.3% on Monday, underperforming the modest rise in the FTSE 100. The shares closed at 33.99 pounds, roughly 17% off their 52-week peak. Attention is shifting to the company’s third-quarter trading update due January 21.

This trading update is crucial since Experian’s main revenue driver is North America, where fees track the volume of credit checks, mortgage inquiries, and fraud screenings. These flows can swing rapidly as rates and lender appetite fluctuate.

Investors are weighing if the U.S. lending environment is truly strengthening to sustain steady growth or merely fluctuating between ups and downs. That uncertainty centers on the trading update, often a key signal for the quarter ahead.

Experian’s financial calendar marks Jan 21 for its third-quarter update. The exchange rate for its first interim dividend will be fixed on Jan 16, with payments going out Feb 6. The company also noted May 20 for its full-year results.

In its November update, Experian signaled it expects total revenue to rise 11% for the year ending March 31, 2026, with organic growth hitting 8% at constant exchange rates. “We delivered strong growth in revenue, earnings and cash flow in H1,” CEO Brian Cassin said then. experianplc.com

Analyst forecasts gathered by the company show an average FY26 revenue projection of $8.43 billion, with EBIT around $2.40 billion. The consensus also expects Benchmark earnings per share to hit 178.7 cents, alongside dividends per share of 70 cents.

In the Jan 21 update, traders will zero in on mortgage enquiries, credit-card and personal-loan checks, plus demand for fraud screening — all volume-driven areas that can shift fast. “Organic” growth, which excludes currency swings and deal impacts, offers a clearer snapshot of the underlying momentum.

Experian goes head-to-head with Equifax and TransUnion in the U.S. credit reporting space, making investors keen to compare all three whenever mortgage or lending figures move. In London, its shares behave more like a financial-information stock, so interest rate forecasts can influence trading even if there’s no fresh company news.

The risk here: a chill in the mortgage market or cutbacks in bank marketing could weigh on volumes, squeezing any margin for error against full-year targets. Currency shifts complicate things further. Experian reports earnings in dollars but trades in pounds, making quarter-to-quarter comparisons a bit messy.

Stock Market Today

  • Tesla Q1 2026 Earnings Beat; Stock Faces Mixed Outlook for 2030
    May 20, 2026, 10:24 AM EDT. Tesla (TSLA) reported Q1 2026 earnings per share (EPS) of $0.41, exceeding the $0.36 consensus, with automotive gross margin rising to 21.1% from 16.2%. Operating income increased 135.8% year-on-year (YoY), and services plus Full Self-Driving (FSD) revenue jumped 42% to $3.75 billion, with 1.28 million active FSD subscriptions up 51%. Despite strong fundamentals, Tesla shares fell 8.83% year-to-date to $409.99 amid skepticism about AI monetization and scaling autonomy. Wall Street's average target is about $412, while a proprietary model estimates a base case price of $510 by 2030, with a bull case of $645. Achieving $650 requires significant price-to-earnings multiple expansion or sharp EPS growth from AI ventures, amid challenges like increased operating expenses and production constraints.

Latest articles

POET Technologies Jumps After $400M AI Photonics Raise, Dilution Questions Linger

POET Technologies Jumps After $400M AI Photonics Raise, Dilution Questions Linger

20 May 2026
POET Technologies shares rose 11% to $14.55 in early Nasdaq trading Wednesday after closing a US$400 million direct offering of 19 million shares and warrants. The rebound followed an 8% drop Tuesday on dilution concerns. The company reported Q1 revenue of $503,389 and a net loss of $12.3 million. A recent $50 million order from Lumilens could scale to $500 million over five years if production ramps up.
Nokia’s U.S. Broadband Order Arrives While AI-Driven Gains Test Supply Chain

Nokia’s U.S. Broadband Order Arrives While AI-Driven Gains Test Supply Chain

20 May 2026
Nokia shares rose 3.37% in Helsinki trading Wednesday after the FCC conditionally approved its Beacons and ONT devices, exempting them from U.S. Covered List restrictions. Nokia also transferred 975,289 treasury shares to equity plan participants. Dell’Oro Group forecasts the optical transport equipment market will grow 16% in 2026, driven by AI data centers.
Apellis Shares Disappear After Biogen’s $5.6 Billion Buy—One Play Left

Apellis Shares Disappear After Biogen’s $5.6 Billion Buy—One Play Left

20 May 2026
Biogen completed its acquisition of Apellis Pharmaceuticals, removing APLS shares from Nasdaq and paying investors $41 per share plus a contingent value right tied to Syfovre sales. Apellis shareholders tendered 82.4% of outstanding stock before the offer expired May 13. Biogen shares rose 0.9% to $192.34 Wednesday. The CVR could pay up to $4 if Syfovre meets future sales targets.
Oracle stock jumps after Goldman’s Buy call as AI buildout costs stay in focus
Previous Story

Oracle stock jumps after Goldman’s Buy call as AI buildout costs stay in focus

Locked out of $22B: Canadian real estate funds freeze withdrawals as gates spread
Next Story

Locked out of $22B: Canadian real estate funds freeze withdrawals as gates spread

Go toTop